'Diabesity' in Clinic: Prevention and Management Medscape InDiscussion: Obesity

Diabetes and obesity are on the rise, and there are new tools to help the prevention and management of this twin epidemic of "diabesity" in primary care. Drs Robert Kushner and Tim Garvey discuss.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982635). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Obesity Treatment & Management https://emedicine.medscape.com/article/123702-treatment
Type 2 Diabetes Mellitus https://emedicine.medscape.com/article/117853-overview
Diabesity https://diabetesjournals.org/clinical/article/40/4/392/147743/Diabesity
National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States https://www.cdc.gov/diabetes/data/statistics-report/index.html
Prevalence of Diabetes by Race and Ethnicity in the United States, 2011-2016 https://pubmed.ncbi.nlm.nih.gov/31860047/
Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017 https://pubmed.ncbi.nlm.nih.gov/34427600/
CDC Diabetes and Obesity Maps https://www.cdc.gov/diabetes/data/center/slides.html
Diabetes Technology: Standards of Care in Diabetes – 2023 https://pubmed.ncbi.nlm.nih.gov/36507635/
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan – 2022 Update https://pubmed.ncbi.nlm.nih.gov/35963508/
Mediterranean Diet and Obesity-Related Disorders: What Is the Evidence? https://pubmed.ncbi.nlm.nih.gov/36178601/
The Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting It https://pubmed.ncbi.nlm.nih.gov/16855180/
Durability of a Primary Care–Led Weight-Management Intervention for Remission of Type 2 Diabetes: 2-Year Results of the DiRECT Open-Label, Cluster-Randomised Trial https://pubmed.ncbi.nlm.nih.gov/30852132/
Semaglutide https://reference.medscape.com/drug/ozempic-rybelsus-wegovy-semaglutide-1000174
Liraglutide https://reference.medscape.com/drug/victoza-saxenda-liraglutide-999449
Tirzepatide Once Weekly for the Treatment of Obesity https://pubmed.ncbi.nlm.nih.gov/35658024/
Glucagon-Like Peptide 1 Receptor Agonists https://www.ncbi.nlm.nih.gov/books/NBK551568/
Dulaglutide Injection https://medlineplus.gov/druginfo/meds/a614047.html
Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors https://www.ncbi.nlm.nih.gov/books/NBK576405/
Incretin Hormones: Their Role in Health and Disease https://pubmed.ncbi.nlm.nih.gov/29364588/
Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Antagonists as Anti-Diabetic Agents https://pubmed.ncbi.nlm.nih.gov/29412817/